Sign in
4

Changes in Ownership

Voyager Therapeutics, Inc. Filed Acc 0001104659-24-024993

Chief Scientific Officer acquired 38,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Carter Todd Alfred · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-09 Grant or award : show line 1 in the form +38,500 91,594 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-09 Grant or award : show line 2 in the form Stock Option (Right to Buy) +77,000 77,000 D
Loading xslF345X05/tm246517-4_4seq1.xml…